Omkar Pharmachem Limited - Due diligence report

A 360° intelligence report on Omkar Pharmachem: trust score, financial health, credit view, compliance, directors, growth and distress signa…

1995-03-31 Ahmedabad, Gujarat Active Listed Active Compliant
Share
OP Omkar Pharmachem Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Omkar Pharmachem — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Omkar Pharmachem is assessed as Moderate with a Trust Score of 74/100. Omkar Pharmachem is an active public limited indian non-government company incorporated in 1995, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Omkar Pharmachem Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
63/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 1 satisfied (10.89 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Gujarat State Financial Co-Op1 48.0 cr
Compliance Score: 63/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: BSE.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 45/100
NameDIN / PANDesignationAppointedTenureDIN status
BHAWANI SHANKAR GOYAL 01234567 Director 01/04/2018 6 yrs Approved
ANUPAM KUMAR MISHRA 01234567 Director 01/04/2018 6 yrs Approved
SHIVAM KAROTIYA 01234567 Director 01/04/2018 6 yrs Approved
SURJEET KAUR 01234567 Director 01/04/2018 6 yrs Approved
JANAK RAJ SHARMA 01234567 Director 01/04/2018 6 yrs Approved
PARMINDER SHARMA 01234567 Director 01/04/2018 6 yrs Approved
Arun Kumar 01234567 Director 01/04/2018 6 yrs Approved
Pankaj Mahadeo Singh 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • JANAK RAJ SHARMA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 3 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a minority stake - exact percentages are part of the full report.

Key managerial personnel: BHAWANI SHANKAR GOYAL (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 1.42.
Operating for 31+ years.
Active GST registration(s).
Distress signals & risk flags
3 director exits within 2 years.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
24 Sep 2025
Last AGM held
Annual general meeting
23 Sep 2025
Director ceased
ANUPAM KUMAR MISHRA
Director ceased
SURJEET KAUR
27 Aug 2025
Director appointed
ANUPAM KUMAR MISHRA (Director)
28 Jun 2025
Director appointed
SURJEET KAUR (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
17 Feb 2025
Director appointed
Pankaj Mahadeo Singh (Company Secretary)
17 Jan 2025
Director ceased
SHIVAM KAROTIYA
12 Aug 2024
Director appointed
SHIVAM KAROTIYA (Company Secretary)
28 Dec 2023
Director appointed
Arun Kumar (Cfo)
30 Mar 2020
Director ceased
MAMTA PACHAURI
14 Feb 2020
Director appointed
BHAWANI SHANKAR GOYAL (Managing Director)
Director ceased
BHAWANI SHANKAR GOYAL
09 Dec 2019
Director ceased
ANURAG SHARMA
30 Sep 2016
Director ceased
JANAK RAJ SHARMA
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
8 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a minority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Intellect Select Private Limited U72900KA2018FTC119498 Bangalore North, Karnataka, India
Germex Pharmaceuticals Private Limited U24231DL2002PTC115604 New Delhi, Delhi, India
Avval Multi Traders (Opc) Private Limited U50404DL2017OPC321961 New Delhi, Delhi, India
Jay Novatech Private Limited U93000MH2016PTC273212 Mumbai, Maharashtra, India
Rolta Developers Private Limited U70109WB2010PTC156433 Baguitai, West Bengal, India
Goldsmith Consortium Private Limited U74999TN2012PTC087992 Madurai, Tamil Nadu, India
Cyan Trading And Exports Private Limited U51909KL2020PTC064530 Kakkanad, Kerala, India
Centauri Enterprises Private Limited U74110WB2007PTC113892 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Omkar Pharmachem before audits and certifications: compliance score 63/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Omkar Pharmachem: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Omkar Pharmachem - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Omkar Pharmachem pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Omkar Pharmachem - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Omkar Pharmachem an active company?

Omkar Pharmachem has MCA status “Active” with a compliance score of 63/100 (Moderate).

Is Omkar Pharmachem financially healthy?

Omkar Pharmachem has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Omkar Pharmachem?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Omkar Pharmachem?

Promoters hold a minority stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Omkar Pharmachem have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Omkar Pharmachem up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 63/100 (Moderate).

Is it risky to lend to Omkar Pharmachem?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.